About us

The History Behind Paindrainer

Paindrainer is based on clinical practise used for management of chronic pain. It is supported by clinical research demonstrating its effectiveness in enhancing quality of life and alleviating pain. The tool is classified as a medical device.

How the Idea was Born and the Results of the First Clinical Study

In 2017, Professor Carl Borrebaeck and Doctor Maria Rosén Klement worked together at Lund University in Sweden. Dr. Klement, who herself experiences chronic pain, had participated in a chronic pain rehabilitation programs where she observed that all program attendees faced a similar challenge. Namely, the level of pain varied daily and was influenced by sleep patterns and daily activities. Dr. Klement recognized that pain is influenced by numerous parameters beyond what the human brain can reasonably track. She shared her insights with Prof. Borrebaeck, noting that advanced calculations could potentially calculate these parameters and aid in pain management.

Subsequently, Dr. Klement and Prof. Borrebaeck enlisted the expertise of IT specialist Göran Barkfors to investigate the feasibility of leveraging machine learning, or artificial intelligence, to help individuals with chronic pain better comprehend their pain and improve their quality of life.

The goal was to create a tool that empowers individuals with chronic, non-malignant pain to comprehend the impact of various activities, and combinations of activities, on their pain levels, thereby enabling them to take charge of their pain management. The Paindrainer digital tool was developed.

In the spring of 2021, a pilot study of Paindrainer was conducted, yielding highly encouraging outcomes. Patients with chronic pain who participated in the study reported improved quality of life and alleviated pain levels after only six weeks of using Paindrainer.

The realization of this vision was made possible through the support of investors, pain management experts, and individuals with chronic pain, who shared the passion and belief of Dr. Klement, Prof. Borrebaeck, and Mr. Barkfors in the potential of their idea to enhance the lives of millions of individuals living with chronic pain.

2018

Paindrainer AB was founded at Medicon Village in Lund by Prof. Carl Borrebaeck, Dr. Maria Rosén Klement and Mr Göran Barkfors.

2019

The first beta-version ready for clinical studies

2021

The first clinical study in co-operation with University of California San Diego Health was finished and published with highly encouraging outcomes.

2022

Clinical studies with Newton-Wellesley Hospital in Boston and Weill Cornell Medicine in New York fortifies Paindrainer's clinical evidence.

Leadership

Board of Directors

Prof. Carl Borrebaeck

Founder and Chairman of the board
expand_more
Read more

Peter Benson

Board Member
expand_more
Read more

Per Antonsson

Board Member
expand_more
Read more

Mattias Ohlsson

Board Member
expand_more
Read more

Philip Siberg

Board Member
expand_more
Read more

Linda Nyberg

Board Member
expand_more
Read more

Management Team

Erik Frick

CEO
expand_more
Read more

Jakob Berglund

CTO
expand_more
Read more

Maria Rosén Klement

Scientific Advisor
expand_more
Read more

Alexandra Johnsson

Marketing and Sales
expand_more
Read more

Advisors

Antje M. Barreveld, M.D.

Medical Director of Pain Management Services and co-Founder and Director of Education and Outreach for Substance Use Services (SUS) at Newton-Wellesley Hospital
expand_more
Read more

Hans Lindroth

Chief Executive Officer at Lingfield AB - Extensive experience in venture investing, asset management and M&A and children's books author.
expand_more
Read more
Contact

Get your free of charge demo version!

To learn more how remote therapeutic monitoring can improve chronic pain management, fill out our form and we will contact you.

Thank you! We have received your details and will get back to you shortly.
Sorry, something went wrong. Please try again.
Our partners

Leading hospitals and pain specialists in Scandinavia and in USA have contributed to the development of  the Medical Device product. Thank you for your support.

FAQ

Frequently Asked Questions about Remote Therapeutic Monitoring

Here you can find common questions and answers. If you're missing any answers, don't hesitate to contact us. We're here to help you!

expand_more
How can we begin working with Paindrainer for RTM services?
To get in touch with us, please send an email to i[email protected] or fill out the contact form on our website.
expand_more
What is required to bill the RTM device codes?
To bill device codes for remote monitoring services, healthcare providers must meet the following requirements: 1) Have an established provider-patient relationship: Providers must have an established relationship with the patient and must have seen the patient in person within the past year or have provided a remote evaluation for the patient within the past six months. 2) Obtain patient consent: Providers must obtain the patient's written consent to participate in remote monitoring services and document the consent in the patient's medical record. 3) Provide patient education: Providers must educate the patient on how to use the remote monitoring device and explain the purpose of the device. 4) Monitor patient data: Providers must regularly monitor the patient's data collected from the remote monitoring device and take appropriate actions based on the data. 5) Document services provided: Providers must document the services provided in the patient's medical record, including the device codes billed and any actions taken based on the data collected. Meeting these requirements will ensure that providers can properly bill for device codes related to remote monitoring services.
expand_more
Who can bill Medicare directly for RTM services?
Healthcare providers who are eligible to bill Medicare for evaluation and management (E/M) services can bill Medicare directly for Remote Therapeutic Monitoring (RTM) services. These eligible providers include physicians, nurse practitioners, physician assistants, clinical nurse specialists, and certified nurse midwives. However, other healthcare providers, such as physical therapists or occupational therapists, may also provide RTM services as part of a collaborative care team and bill for their services through the eligible provider. It's important to note that specific Medicare coverage and payment policies for RTM may vary depending on the type of service provided and the geographic location of the patient and provider.
expand_more
Is RTM intended to be used for non-physiological data?
Yes, RTM is intended to be used for non-physiological data. This includes data related to a patient's therapeutic response, such as medication adherence, symptom management, and therapy response. While Remote Patient Monitoring (RPM) focuses on physiological data like heart rate and blood.
expand_more
Why is Remote Therapeutic Monitoring important?
Remote Therapeutic Monitoring (RTM) is important for several reasons: 1) Improved Patient Outcomes: RTM allows healthcare providers to remotely monitor patients and intervene if necessary, which can lead to improved patient outcomes. By closely tracking a patient's therapeutic response, healthcare providers can adjust treatment plans as needed to optimize outcomes and prevent complications. 2) Better Management of Chronic Conditions: RTM can be particularly useful for managing chronic conditions, such as diabetes or mental health disorders. By monitoring medication adherence and therapy response, healthcare providers can help patients better manage their conditions and avoid exacerbations. Increased 3) Access to Care: RTM can also improve access to care for individuals who have difficulty accessing traditional in-person healthcare services, such as those living in rural or remote areas. By using technology to remotely monitor patients, healthcare providers can provide care to patients who may not be able to travel to a healthcare facility. 4) Cost-Effective: RTM can be cost-effective for both patients and healthcare providers. By reducing the need for in-person visits, RTM can lower healthcare costs and improve efficiency. It can also reduce the burden on patients, who may not need to take as much time off work or travel long distances for healthcare appointments. Overall, RTM has the potential to improve healthcare outcomes, increase access to care, and lower healthcare costs, making it an important tool for healthcare providers and patients alike.
expand_more
How do Remote Therapeutic Monitoring and Remote Patient Monitoring differ?
Remote Patient Monitoring (RPM) and Remote Therapeutic Monitoring (RTM) are two different approaches to use technology to remotely monitor patients. RPM collects physiological data like heart rate and blood pressure. RTM collects non-physiologic data related to a patient's therapeutic response, such as medication adherence, symptom management, and therapy response. RTM can be used to monitor and manage a wide range of conditions, such as mental health, musculoskeletal conditions, respiratory diseases, and more.
expand_more
What is Remote Therapeutic Monitoring?
Remote Therapeutic Monitoring (RTM) refers to the use of technology to remotely monitor a patient's health status and treatment progress, typically for individuals with chronic or complex medical conditions. RTM can collect a wide range of non-physiological data related to a patient's therapeutic response, including respiratory system status, musculoskeletal system status, medication adherence, and medication response, without requiring them to come into the office for frequent check-ins.
More frequent questions